1. Home
  2. GLU vs SEER Comparison

GLU vs SEER Comparison

Compare GLU & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Global Utility of Beneficial Ownership

GLU

Gabelli Global Utility of Beneficial Ownership

N/A

Current Price

$19.12

Market Cap

119.8M

Sector

Finance

ML Signal

N/A

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$1.72

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLU
SEER
Founded
2004
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.8M
97.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GLU
SEER
Price
$19.12
$1.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.1K
197.6K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
8.60%
N/A
EPS Growth
N/A
9.40
EPS
0.62
N/A
Revenue
N/A
$16,578,000.00
Revenue This Year
N/A
$2.14
Revenue Next Year
N/A
$25.90
P/E Ratio
$30.69
N/A
Revenue Growth
N/A
16.99
52 Week Low
$16.60
$1.65
52 Week High
$21.69
$2.41

Technical Indicators

Market Signals
Indicator
GLU
SEER
Relative Strength Index (RSI) 42.81 38.38
Support Level $18.91 $1.69
Resistance Level $20.17 $1.96
Average True Range (ATR) 0.33 0.05
MACD -0.03 -0.01
Stochastic Oscillator 62.20 15.38

Price Performance

Historical Comparison
GLU
SEER

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Share on Social Networks: